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ABSTRACT 
The effects of vinblastine and colchicine on pancreatic acinar cells were studied by 
use of in vitro mouse pancreatic fragments.  Vinblastine  inhibited  the  release of 
amylase stimulated by bethanechol,  caerulein,  or ionophore A23187.  Inhibition 
required  preincubation  with vinblastine,  and maximum inhibition  was observed 
after 90 min. Inhibition was relatively irreversible and could not be overcome by a 
high concentration of stimulant.  Inhibition could also be produced by colchicine 
although  longer  preincubation  was  required  and  inhibition  was  only  partial. 
Uptake of [3H]vinblastine and  [3H]colchicine  by pancreatic fragments was mea- 
sured and found not to be responsible for the  slow onset of inhibition  by these 
drugs.  In incubated  pancreas, microtubules were present primarily in the apical 
pole of the cell and in association with the Golgi region. Vinblastine,  under time 
and dose conditions that inhibited the release of stimulated amylase, also reduced 
the  number  of  microtubules.  The  only  other  consistent  structural  effects  of 
vinblastine  were  the  presence  of vinblastine-induced  crystals  and  an  increased 
incidence of autophagy. The remainder of cell structure was not affected nor were 
overall tissue ATP and electrolyte contents or the stimulant-induced  increase in 
45Ca++  efflux.  It  is  concluded  that  the  antisecretory  effects of vinblastine  and 
colchicine are consistent with a microtubular action, but that acinar cell microtu- 
bules are more resistant to the drugs than many other cell types. 
Microtubules have been implicated in the release 
of a number of hormones and proteins including 
insulin  (15-17,  20),  thyroid  hormones  (10,  40, 
43,  44),  catecholamines (28,  29),  pituitary hor- 
mones  (11,  14),  parathyroid  hormone  (8,  30), 
collagen (9), salivary gland glycoprotein and amy- 
lase (6, 33), low density lipoproteins (24, 37), and 
albumin and other plasma proteins (18, 31). Most 
of this  work  is  based  on  the  use  of antimitotic 
drugs known to exert an effect on microtubules, 
especially  colchicine  and  the  vinca  alkaloids. 
These agents interact with the primary microtubu- 
lar protein, tubulin (45), and cause the disappear- 
ance of formed microtubules. 
Microtubules have been observed in all types of 
cells examined since the advent of aldehyde fixa- 
tion, and a protein presumed on the basis of its 
colchicine-binding  activity  to be tubulin  has also 
been found in a number of secretory tissues (5, 22, 
36, 44). It is not clear, however, whether all of the 
antisecretory actions of antimitotic drugs are me- 
diated by an effect on microtubules since, in many 
cases, high concentrations of the drugs have been 
used which may produce other effects (45).  Fur- 
thermore, in some cases minimal or no inhibition 
has been  observed,  although  generally no  mor- 
phological  studies were carried out to determine 
that microtubules had been affected. It is thus not 
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part of a general mechanism for protein packaging 
and  release.  Possibly,  differences  observed  in 
studies of different secretory processes may reflect 
an inherent difference in microtubules or in tissue 
penetration of the drugs. 
While the pancreatic acinar cell has been a pro- 
totype for studies of protein synthesis and packag- 
ing  (12,  26),  only  recently  have  studies  on  the 
control  of digestive enzyme  release  been carried 
out. Cholinergic agonists and the hormone chole- 
cystokinin-pancreozymin, which stimulate massive 
discharge  of  enzymes,  depolarize  the  cell  and 
release  intracellular Ca  ++  (7,  21,  27).  A  rise  in 
intracellular  free  Ca ++  is  believed  to  increase 
release  of zymogen granule  contents by exocyto- 
sis. 
In  the  present  work,  the  effect  on  pancreatic 
amylase release of agents acting on microtubules, 
particularly  vinblastine,  has  been  studied.  We 
have investigated:  (a)  to  what extent vinblastine 
and choichicine inhibit protein secretion from pan- 
creatic exocrine cells; (b) where in the sequence of 
stimulus-secretion  coupling  this  inhibition  takes 
place;  (c)  whether this inhibition can  indeed  be 
correlated with the disappearance of microtubules 
from  these  cells;  and  (d)  what  structural  conse- 
quences of the loss of microtubules might explain 
the inhibition of protein secretion. The slow onset 
and limited  effectiveness of these  drugs  on  pan- 
creatic tissue which we observed further motivated 
us  to  determine  whether  their  tritiated  analogs 
were actually taken up by the tissue. 
MATERIALS  AND  METHODS 
All studies were  carried out with pancreases obtained 
from  male  White  Swiss  mice  which  had  been  fasted 
overnight before  use.  The  pancreas was removed and 
divided into four or five 20-25-mg fragments which were 
incubated in 3 ml Krebs-Henseleit bicarbonate (KHB) 
medium equilibrated with 95% 02-5% CO2 (41). Incu- 
bation was carried out in 25-ml Erlenmeyer flasks main- 
tained at 37~  and shaken at 90 cycles/rain. A  preincu- 
bation was carded out to allow washout of amylase from 
damaged  cells  and  for  penetration  and  action  of  the 
compounds studied. Incubation for 30 min in the pres- 
ence or absence of secretagogues was used to measure 
stimulation of amylase release. ~Ca ++ efflux was mea- 
sured with a perfusion apparatus as previously described 
(41). 
Analytical Procedures 
Amylase activity released into the medium by pan- 
creatic fragments was assayed by the method of Rinder- 
knecht et al. (32) using the dye-coupled substrate, amy- 
lose azure. ATP was measured in perchloric acid extracts 
of pancreatic fragments fluorometrically by the method 
of  Lowry  et  al.  (19).  Pancreatic  total  water  content, 
inulin space, and Na  + and K + content were determined 
as  previously reported  (39).  Uptake  of  [3H]colchicine 
and vinblastine was measured as previously described in 
studies on thyroid glands (40, 43). Thin layer chroma- 
tography on silica gel plates was used to establish purity 
of the radiolabeled compounds and to check for tissue 
metabolism  (40,  43).  After  incubation  of  pancreatic 
fragments for the specified time with medium containing 
the  radioactive  compound,  the  tissue  was  rinsed, 
weighed, and dissolved in 0.5 ml Protosol (New England 
Nuclear, Boston, Mass.). 10 ml of scintillation fluid con- 
sisting of 2  vol toluene to  1 vol Triton X-100 contain- 
ing 4 g/liter butyl PBD was added and, after the decay 
of  chemiluminescence,  radioactivity  was  measured. 
Quenching was corrected by use of an internal standard. 
Electron Microscopy 
Pancreas was fixed for 90 min at 37~  in 1.5% glutar- 
aldehyde-l% paraformaldehyde in 0.08 M sodium caco- 
dylate buffer, pH 7.4. Tissue was postfixed in 2% OsO4 
in 0.08 M cacodylate at 2~  for 2 h and then dehydrated 
in ethanol, passed through propylene oxide, and embed- 
ded  in  British  Araldite.  Thin  sections  were  doubly 
stained with uranyl acetate and lead citrate and exam- 
ined in a JEM 100B electron microscope at 60 kV. For 
estimation of microtubular content sections were photo- 
graphed at a magnification of 12,000 and photographi- 
cally  enlarged to a  magnification of 30,000.  For each 
experimental condition at least 10 prints were examined 
from each of five pancreases. In all cases control as well 
as  drug-treated  pancreatic  fragments  from  the  same 
mouse were processed and examined. 
Materials 
Colchicine was obtained from Sigma Chemical Co., 
St. Louis, Mo.,  [3H]colchicine  from New England Nu- 
clear, Boston, Mass.,  and caerulein from Calbiochem, 
San  Diego,  Calif.  Vinblastine and A23187  were  gifts 
from  Dr.  Robert  Hammil  of Eli  Lilly  and Company, 
Indianapolis, Ind. [3H]Vinblastine was a gift from Dr. J. 
Wolff of the National Institutes of Health and had been 
prepared by a modification (5) of the method of OweUen 
and Donigan (25). 
Vinblastine and colchicine were dissolved directly in 
KHB.  Stock solutions of bethanechol and caerulein in 
water were prepared and an aliquot was added to pro- 
vide the specified concentration. The calcium ionophore 
A23187  was  dissolved  in  ethanol  with  an  equivalent 
amount of ethanol (0.5%) added to control flasks. 
RESULTS 
The  effect of vinblastine on basal and stimulated 
amylase  release  from  in  vitro mouse  pancreas  is 
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10-8-10 -4  M  had  little  effect  on  basal  amylase 
release but reduced release stimulated by bethane- 
chol  and  caerulein in  a  concentration-dependent 
manner.  Since  release  evoked  by  caerulein  was 
inhibited  to  the  same  extent  as  that  evoked  by 
bethanechol, vinblastine must be inhibiting more 
than just the cholinergic receptor. A  standard 90- 
min period of preincubation was chosen after ex- 
periments shown  in  Fig.  2  had  been carried  out 
with varying lengths of preincubation. When vin- 
blastine  was  present  only  during  stimulation  of 
release  there was no inhibition, while preincuba- 
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FIGURE  1  Effect of vinblastine on basal, bethanechol- 
stimulated,  and caerulein-stimulated amylase release by 
mouse  pancreas  in  vitro.  Pancreatic  fragments  were 
preincubated for 90 rain in the specified concentration of 
vinblastine and then incubated for 30 rain in the same 
medium with bethanechol (3-10  -s M) or caerulein (10 
ng/ml) added as indicated. All values are the mean •  SE 
for five to eight pancreases. 
tion with the drug for 30  rain before  stimulation 
led to a  maximum of about 50%  inhibition, and 
preincubation for 90 min led to a maximum of 85- 
90% inhibition. After 90 min preincubation with 
vinblastine, it was not necessary to have the drug 
present during the incubation period, as shown in 
Table I. In other words, there was no rapid revers- 
ibility of  vinblastine  inhibition once  established. 
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Effect of preincubation time on the vinblas- 
tine inhibition of bethanechol-stimulated pancreatic am- 
ylase  release  by mouse  pancreas in vitro.  Each curve 
represents pooled data from experiments such as shown 
in Fig. 1 and is constructed by subtracting basal from the 
bethanechol-stimulated amylase release for each concen- 
tration of vinblastine and expressing it as the percent of 
control stimulation. Thus,  100%  is the difference be- 
tween bethanechol-stimulated and basal amylase release 
in the absence of vinblastine. 
TABLE  I 
Absence of  Rapid Reversibility o  f Vinblastine Inhibi- 
tion o  fin Vitro Pancreatic Amylase Release 
Amylase release (U/rag/30  rain) 
Bethanechol 
Addition to medium  Unstimulated  (3.10 -s M) 
None  0.28 •  0.03  1.31  •  0.11 
Vinblastine 
Preincubation  and  0.26 •  0.03  0.41  •  0.03 
incubation 
Vinblastine 
Preincubation only  0.21  •  0.02  0.41  •  0.03 
Pancreatic  fragments were  sequentially  incubated  for 
900,  600,  and 30-min periods.  Vinblastine (3.10 -5 M) 
was  present  during  the  initial  90  rain  (preincubation 
only) or during the entire period (preincubation and in- 
cubation)  as  specified.  Unstimulated  or  bethanechol- 
stimulated  amylase  release  was  measured  during  the 
terminal 30-min incubation. All values are the mean • 
SE of 9-12 pancreases. 
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bethanechol in the presence of a submaximal con- 
centration of vinblastine were  studied,  there  was 
no indication that a  high concentration of stimu- 
lant  could  overcome  the  vinblastine  inhibition 
(Fig. 3). Both the relative irreversibility and "non- 
competitive"  nature  are  similar  to  results  of  a 
recent  study  of  vinblastine inhibition of  in  vitro 
thyroid secretion (40). 
Recently,  it has become possible to bypass the 
early steps of stimulus-secretion coupling by use of 
the  calcium  ionophore  A23187  to  artificially in- 
troduce Ca ++ into the pancreatic cell and stimulate 
amylase release (35, 42). Vinblastine was found to 
inhibit  amylase  release  initiated  by  A23187  as 
shown in Table II. That vinblastine is inhibiting a 
later, rather than an earlier step in stimulus-secre- 
tion coupling is confirmed by the finding that the 
increased  efflux  of  45Ca++  from  prelabeled  pan- 
creatic fragments is not affected by a high concen- 
tration of vinblastine. An example of the bethane- 
chol-stimulated  efflux  of 45Ca++  and  the  lack  of 
effect of vinblastine is shown in Fig.  4.  In seven 
experiments with vinblastine at a concentration of 
3.10 -~ M, which inhibits amylase release by about 
75%  (Fig.  2),  the  maximum  increase  in  *sCa ++ 
effiux was 215%  +- 31% as compared to 180%  -+ 
21%  for the increase  measured when vinblastine 
was absent. 
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FIGURE  3  Effect  of  vinblastine  on  amylase  release 
from mouse pancreas induced by varying concentrations 
of bethanechol. Amylase release was measured during a 
30-min incubation period after 90  min preincubation, 
both carried  out  in  the  presence  (IN-II)  or  absence 
(@-@) of vinblastine (10  -5 M). All values are the mean 
-  SE for five to seven pancreases. 
TABLE  II 
Inhibition  of Bethanechol- and A23187-stimulated 
In  Vitro Pancreatic Amylase Release by Vinblastine 
Amylase release (U/mg/30 rain) 
Bet hancchol  A23187 
Vinblastine  Unstimulated  (3.10  -s M)  (l" 10  -~ M) 
0  0.25 +- 0.02  0.87 +- 0.09  0.49 +- 0.03 
10  -4 M  0.26 --- 0.04  0.34 _+ 0.03  0.28  -  0.03 
Pancreatic fragments were preincubated for 90 min in 
medium with or without vinblastine and then incubated 
for 30 min in new medium with the addition of bethane- 
chol or A23187 as specified. All medium contained the 
normal concentration of Ca  ++ (2.56 mM). All values are 
the mean --- SE of five to seven values. 
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FIGURE  4  Lack of effect of vinblastine on the bethane- 
chol-stimulated increase  in  ~Ca  ++  efflux  from  mouse 
pancreas in vitro. Fractional efflux of *~Ca  ++ is plotted 
as a function of washout time after 1 h of loading with 
*~Ca  ++. Bethanechol (3.10 -5 M) was added at 90 min 
(black bar) to both halves of a  mouse pancreas super- 
fused separately with KHB (@) or KHB with 3' 10  -5 M 
vinblastine (O). 
Inhibition  of  bethanechol-stimulated  amylase 
release could also be produced by colchicine which 
interacts with  the  microtubule  at  a  different site 
from vinblastine. As shown in Fig. 5, it was neces- 
sary to use high concentrations of coichicine and a 
long preincubation time to inhibit amylase release 
to any significant extent. 
Uptake  of vinblastine and colchicine into pan- 
creas does not appear to be a  rate-limiting factor 
for  inhibition of  secretion.  As  shown  in  Fig.  6, 
both vinblastine and colchicine rapidly accumulate 
in  pancreas with  tissue:medium  ratios as  high as 
40 for vinblastine and 7 for colchicine. There was 
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tracted compound chromatographed similarly to 
the  original material.  About  10  times as  much 
vinblastine is taken up as colchicine, and the vin- 
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FmuaE  5  Effect of colchicine  on  basal and  bethane- 
chol-stimulated amylase release  by  mouse pancreas in 
vitro. Pancreatic fragments were preincubated for 150 or 
210 min in the specified concentration of colchicine and 
then  incubated  in  the  same  medium  with  or  without 
bethanechol (3.10 -5 M). All values are the mean •  SE 
for four to nine pancreases. 
blastine uptake curve shows more than one kinetic 
component. Both the rapid component of vinblas- 
tine uptake and all of colchicine uptake are largely 
complete  at  a  time  when  microtubules are  still 
present, as will be shown later. While the relation 
of tissue  uptake  to  microtubular binding of the 
drugs is not clear, slow entry of the drugs into the 
cell appears unlikely as an explanation of the high 
concentrations  and long preincubation  time neces- 
sary to inhibit amylase release. 
Electron microscope studies were carried out to 
assess the effects of the compounds used on pan- 
creatic fine structure.  In control incubated pan- 
creas,  microtubules were  found primarily in the 
apical portion of the cell and in the Golgi region as 
shown in Fig. 7. There was no obvious structural 
relationship between microtubules and the zymo- 
gen granules, the apical membranes, or other or- 
ganelles. In pancreatic fragments incubated with 
3.10  -5 M vinblastine  for 90 min, such as shown in 
Fig. 8, microtubules were  no longer discernible, 
although most other aspects of the cell structure 
and organization appeared normal. When tissue 
was examined after only 30 min in medium con- 
taining a  similar concentration of vinblastine, a 
few microtubules were  invariably present. After 
90 or 150 min incubation with vinblastine at con- 
centrations  of  3.10-5-10  -4  M,  vinblastine-in- 
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FmuPm  6  Uptake of [aH]vinblastine (left panel) and  [aH]colchicine  (right panel) by mouse pancreatic 
fragments in vitro.  Drug concentration  in the  tissue is plotted  as a  function of time  for  the  medium 
concentrations shown. All points are the mean -+ SE for three to five pancreases. 
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number  of  autophagic  vacuoles.  Colchicine 
(3.10 -s M) was also found to reduce or abolish 
microtubules but only after 150 or 210 min incu- 
bation; no effect was seen after 90 min incubation. 
As shown in Figs. 9 and 10, prolonged incubation 
with  vinblastine (210  min,  3-10  -5  M)  had  no 
effect on the general organization of the internal 
membrane compartments of the cells even though 
microtubules must  have  been  absent  for  some 
time. 
While  the  antisecretory effects  of  vinblastine 
and colchicine are consistent with a microtubular 
site of action, other possibilities should be consid- 
ered, especially because of the high concentrations 
of the agents used. Pancreatic secretion is known 
to be dependent on metabolic energy. Agents such 
as DNP and cyanide will inhibit stimulated amy- 
lase release, presumably by reduction of cellular 
ATP  (13).  Table  III shows  the  effects  of  high 
concentrations of  vinblastine and  colchicine on 
mouse pancreatic ATP content. While DNP and 
cyanide each reduced ATP levels by over 90%, 
neither vinblastine nor colchicine had any effect. 
To  analyze  further  the  functional intactness of 
pancreatic  cells,  water,  sodium,  and  potassium 
content were  measured. As shown in Table IV, 
these indices of cell membrane integrity were not 
affected by vinblastine or colchicine. 
DISCUSSION 
The  present work  clearly shows that  antimitotic 
agents known to  affect  microtubules can inhibit 
the  stimulation of  pancreatic  amylase  release  if 
applied for a long enough period of time. Earlier 
negative results (4, 12) used shorter preincubation 
times  which  in  our  studies  also  produced  little 
inhibition. These results again point out the need 
for  preincubation in in vitro studies with  drugs 
affecting microtubules (43, 44), and suggest the 
necessity of morphological confirmation that the 
drugs  have  in fact  affected  microtubules before 
one concludes that microtubules are not necessary 
for secretion. That the drugs are affecting protein 
release and not synthesis is shown by the normal 
content of zymogen granules (Figs.  8,  10)  and 
amylase  content  (J.  A.  Williams,  unpublished 
data).  Jamieson (12)  also found that concentra- 
tions of colchicine and vinblastine  lower than 10  -4 
M did not inhibit incorporation of [3H]leucine into 
guinea pig pancreas. 
The  striking inhibition of  stimulated  amylase 
release contrasts with the slight degree of inhibi- 
tion of basal release. While this suggests that the 
two  types  of  release  occur  by  separate  mecha- 
nisms, it is not clear how much of basal release is 
due to leakage from damaged cells. Inhibition of 
stimulated but not  basal  amylase release  is  not 
unique to antimitotic agents. Similar inhibition is 
produced  by metabolic inhibitors (13),  removal 
of Na  + from the  medium (39),  tetracaine  (42), 
and  cytochalasin B  (2;  J.  A.  Williams, unpub- 
lished data). 
Since vinblastine  was more effective than coichi- 
cine in inhibiting stimulated amylase release, we 
examined its uitrastructural effects in more detail. 
Microtubules were normally present in the apical 
pole of the pancreatic cell and in the Golgi region. 
No  obvious structural relation between microtu- 
bules  and  granules  or  luminal membrane  was 
seen, nor was there obvious change in number or 
location of  microtubules in  pancreas stimulated 
with bethanechol or A23187 (unpublished data). 
Vinblastine  essentially  abolished  microtubules, 
while other structures in the apical pole of the cell 
remained normal  (Fig.  8).  At  short  incubation 
times (30 min for vinblastine, 90 min for colchi- 
cine)  when  inhibition was  negligible or  incom- 
plete, microtubules were  present. In addition to 
TABLE III 
Effect of Microtubule-Active Drugs and Metabolic 
Inhibitors on A TP Content of Mouse Pancreas in 
vitro 
Addition to medium  ATP content 
None 
Vinblastine (10  -4 M) 
Colchicine (10  -4 M) 
Cyanide (10  -a M) 
Dinitrophenoi (2.10  -4 M) 
nmol/mg 
2.59 •  0.20 (9) 
2.33 •  0.14 (6) 
2.86 •  0.13 (6) 
0.19 •  0.07 (6) 
0.t7 --+ 0.06 (6) 
Pancreatic fragments were incubated in KHB with the 
specified addition for 90 min. All values are the mean - 
SE of the number of values shown in parentheses. 
FIGURE 7  Electron micrograph of mouse pancreas incubated for 90 min in KHB. Microtubules indicated 
by arrows are found around the acinar lumen (L) and in the Golgi area (G). Z, zymogen granules, x 
28,000. Bar =  1 /.tm. 
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Effects of Vinblastine  and Colchicine on Pancreatic Water and Electrolytes 
Additions to medium  Total HIO  Inulin space  Na  +  K + 
%  %  nmollmg  nmolmg 
None  81.21 -+ 0.42  27.0 --- 0.9  81.5 -  2.8  95.1 --- 1.6 
Vinblastine (10  -4 M)  80.39 --- 0.81  26.8 •  1.1  81.8 •  4.4  98.6 •  3.2 
Colchicine (10  -4 M)  81.57 •  0.41  26.0 •  1.0  76.8 •  4.0  104.5" -+ 2.6 
Mouse pancreatic fragments were incubated for 3 h in KHB containing 0.3 /~Ci/ml [all]inulin and the additions 
specified before determination of water and electrolyte contents. All values are the mean -  SE for five determina- 
tions. 
* P < 0.05 as compared to control. 
causing  the  disappearance  of  normal  microtu- 
bules, vinblastine at concentrations of 3.10 -5 M 
or higher induced characteristic crystalloid struc- 
tures  (3)  and frequent autophagic vacuoles (1). 
The  overall cell  polarity was  not,  however,  af- 
fected by vinblastine even after prolonged incuba- 
tion so that formed microtubules should have been 
absent for several hours (compare Figs. 9 and 10). 
Thus,  other  factors  besides  microtubules  must 
contribute to overall maintenance of cell shape in 
pancreatic acini. 
Morphological studies are thus consistent with a 
microtubular  site  of  action  for  the  antimitotic 
drugs and suggest that the delayed inhibition re- 
flects  a relative resistance of the microtubules in 
pancreatic cells to the drug. Vinblastine appears to 
act faster than colchicine as in the case of inhibi- 
tion of thyroid secretion (40).  In both the  pan- 
creas  (Fig.  6)  and  the  thyroid  (40,  44),  tissue 
uptake of the drugs is rapid. The relation between 
tissue uptake, binding to tubulin, and disaggrega- 
tion of tubules, as well as the possibility of alterna- 
tive  binding sites,  remains to  be  established. A 
possible explanation of the delayed action is that 
the drugs prevent only polymerization of microtu- 
bules, and the  rate  of disappearance of formed 
microtubules depends  on  the  rate  of  continual 
turnover. 
While the current data showing parallel inhibi- 
tion of stimulated amylase release and disappear- 
ance of acinar cell microtubules are consistent with 
a  requirement  for  microtubules  in  amylase 
release, other possibilities have been considered. 
Pancreatic secretion is acutely dependent on meta- 
bolic energy and is inhibited by blockers such as 
cyanide and dinitrophenol (13). Vinblastine does 
not appear to act in this mode, since ATP levels as 
well as tissue Na  + and K + levels are unaffected. 
Membrane  stabilizers such  as  local  anesthetics, 
tranquilizers, and detergents will inhibit amylase 
release  (42;  J.  A.  Williams, unpublished data) 
and vinblastine can, at high concentrations, act as 
such an agent (34). Inhibition of pancreatic secre- 
tion,  however,  occurs  at  lower  concentrations. 
Furthermore,  membrane  stabilizers  block  the 
bethanechol-stimulated increase in ~sCa++ efflux 
while vinblastine does not (Fig. 5). While alterna- 
tive mechanisms of action cannot be eliminated, at 
least vinblastine and colchicine do not appear un- 
der present conditions to be inhibiting  secretion by 
acting as general cell poisons. Larger amounts of 
vinblastine in vivo, however, have been shown to 
cause  toxic  necrosis of the  pancreas after  24  h 
(23). 
If  antimitotic  agents  are  inhibiting  amylase 
release by abolishing formed microtubules, then 
the  role  of  microtubules in the  release  process 
must be considered. Knowledge of how microtu- 
bules participate in secretion is a problem faced in 
studies of a number of secretory cells and one for 
which there is at present no clear solution. Various 
workers  have  suggested  that  microtubules may 
guide  granules to  the  membrane  (16),  interact 
with microfilaments (20), or organize the distribu- 
tion of cell membrane components (38). Further 
work  is  in  progress  to  distinguish among  these 
possible mechanisms for  microtubular participa- 
tion in the secretory process. 
FIGURE 8  Electron micrograph of apical area of mouse pancreas incubated 90 min in KHB with 3.10  -5 
M vinblastine. Microtubules are absent but other cell constituents are normal. Labels as in Fig. 7.  x 
28,000. Bar =  1 /zm. 
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